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Abstract   
Introduction: Many patients suffer from mild, moderate or severe pain during or after root 
canal therapy. Theoretically, post-operative pain control can be achieved by using long-acting 
local anesthetics. The aim of this study was to evaluate the efficacy of a long acting anesthesia, 
bupivacaine, on preventing post-operative pain associated with endodontic treatment, and to 
compare it with lidocaine. 
Materials and Methods: This study was a double blind and randomized clinical trial on 
30 patients' anterior maxillary teeth. The patients were divided into two groups of fifteen. One 
group was administered lidocanine (2% with 1:100000 epinephrine) local anesthesia and the 
other group was given bupivacaine (0.5% without epinephrine). The pain in patients were 
compared using the visual analogue scale (VAS) at definite times i.e. before treatment, during 
treatment and 2,4,6,8,10,12,24,36 and 48 hours after operation. Data were analyzed using One-
way ANOVA tests.  
Results: Bupivacaine significantly decreased postoperative pain compared to lidocaine. 
Postoperative pain was directly related to preoperative pain. Women reported more pain, though 
significant difference in postoperative pain report was not found between different ages. 
Conclusion: In conclusion, a single dose of bupivacaine 0.5% used in infiltration anesthesia 
could be more effective in reduction or prevention of post-operative endodontic pain compared 
with lidocaine. [Iranian Endodontic Journal 2010;5(1):31-5] 
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Introduction 
The perceived association of pain with 
endodontic therapy is a great source of fear for 
many patients and can prevent them from 
seeking treatment (1). Controlling post-
operative pain represents a meaningful 
challenge to many practitioners (2). Local 
anesthetics provides adequate pain relief for the 
majority of dental treatments, however, failures 
do occur. These may be the result of 
anatomical, pharmacological, pharmaceutical, 
pathological, psychological or technical or 
iatrogenic factors (3-6). 
An objective of endodontic therapy is to relieve 
and/or prevent patient pain. Good anesthetic 
technique can considerably eliminate pain 
during treatments; but, post-treatment 
endodontic pain remains a significant 
predicament (7). Post-operative pain control is 
frequently performed with the administration of 
short-acting local anesthetic and oral 
analgesics. Theoretically, pain control can be 
increased by using a local anesthetic with 
prolonged action (8-10). 
A range of local anesthetic drugs have been 
used in dentistry. Lidocaine, the first 
commercialized amide local anesthetic, is still 
the most widely used anesthetic in some 
countries (11). It is considered as a reference 
for new local anesthetics (12). Clinical trials 
with long-acting anesthetic (bupivacaine and 
etidocaine)  have  been  performed  in  patients  
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Table 1. studied groups with local anesthetic  
Group n Gender Age (mean) Year Male Female 
1* 15 8 7 18-54 (32.4) 
2† 15 9 6 28-61 (41.4) 
*Lidocaine 2% + epinephrine 1:100000   
†Bupivacaine 2% without epinephrine 
 
undergoing oral surgery, endodontic treatment, 
and periodontal treatment (13-16). Etidocaine 
was recently withdrawn from the market by 
Dentsply Pharmaceuticals. Bupivacaine, an 
amide-type local anesthetic, provides prolonged 
analgesia and is indicated when post-operative 
pain is anticipated (17). Its use in routine oral 
surgery is especially justified for lengthy 
surgical procedures or oral surgical extraction 
associated with predicted post-operative pain 
and discomfort (8,18). 
There are many studies on effectiveness and 
efficient use of bupivacaine for controlling pain 
after various types of surgery. Gozal et al. 
found that using bupivacaine in thyroid surgery 
significantly decreased post-operative pain   
and the need for analgesic drugs in these 
patients (19). 
Many studies on patients undergoing surgical 
removal of impacted third molar showed that 
bupivacaine significantly decreased post-
operative pain and the need for the analgesic 
drugs compared to short-acting anesthetics  
(20-22). 
Crout et al. studied the effectiveness of long-
acting anesthesia to reduce pain after 
periodontal surgery. They concluded that 
etidocaine postpones the onset of pain and 
using only lidocaine induced more analgesics 
use by patients. Also there was no significant 
difference between etidocaine and bupivacaine 
in both quality and quantity of anesthesia and 
post operative pain (14). Fernadez et al. 
compared the amount of pulpal anesthesia 
obtained with bupivacaine and lidocaine in 
inferior alveolar nerve blocks. They reported 
significant anesthetic success with lidocaine for 
all teeth except the first molars (23). Moore and 
Dunsky observed no significant difference 
between lidocaine and bupivacaine in the onset 
of anesthesia and numbing depth in root canal 
treatment. The greatest difference between 
lidocaine and bupivacaine was related to the 
duration of anesthesia and post-operative 
discomfort,  this  is  because  significantly more  
patients reported pain in the lidocaine group (2).  
Most of these studies investigated the efficacy 
of bupivacaine in dental and periodontal 
surgeries. Nevertheless, the anesthetic efficacy 
of bupivacaine in providing pulpal anesthesia 
for teeth with irreversible pulpitis and its ability 
to prevent post-endodontic pain needs further 
investigation. Therefore, the purpose of this 
prospective, randomized, double-blind clinical 
study was to evaluate the efficacy of long 
acting anesthesia (bupivacaine) to prevent post-
operative pain associated with endodontic 
treatment, and to compare it with lidocaine. 
 
Materials and Methods 
The Institutional Ethics Committee of Mashad 
University of Medical Sciences approved the 
protocol and the informed consent documents 
of this study. All patients provided written 
informed consent before being enrolled. Thirty 
adult patients (13 women and 17 men), with an 
age range of 18-61 years participated in this 
randomized, double-blind clinical trial. They 
were referred to the Department of 
Endodontics, Mashad Dental School. 
Inclusion criteria were healthy persons (ASA I 
or II), who required endodontic treatment in 
upper anterior vital teeth with a clinical 
diagnosis of irreversible pulpitis and no history 
of root canal therapy. Exclusion criteria 
included allergy to amide local anesthetics, 
pregnancy or lactation, any endocrine or 
infectious disease, moderate to advanced 
periodontal disease, nonvital teeth (necrosed).  
Bupivacaine was provided from 20 mL 
Marcaine vials (0.5%, 5mg/mL, Astra co., 
Sweden) and inserted into the lidocaine 
cartridges that were emptied previously, and 
the cartridges were coded by a person who was 
not directly involved in data collection. 
Each patient rated his or her initial pain on a 
10-cm Visual Analogue Scale (VAS) with a 
range of no pain (0 cm) and unbearable pain 
(10 cm). These 30 patients were randomly 
divided into two study groups. 
Group 1 received 1.8 mL of lidocaine 2% with 
1:100.000 epinephrine (Darou Pakhsh co., 
Tehran, Iran). Group 2 received 1.8 mL of 
bupivacaine 0.5% without epinephrine (Astra 
co, Sweden) (Table 1). Topical anesthetic gel 
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Figure 1. Comparative Visual Analogue Scale in: A) bupivacaine + lidocaine B) patients>40 and <40 
years old and C) males and females  
 
infiltration site for 60 seconds using a cotton-
tip applicator. Then the two local anesthetic 
injections were given by using a standard 
dental aspirating syringe fitted with a 27-gauge, 
1.5-inch needle. One operator performed all of 
the anesthetic procedures. This operator was 
not involved in data analysis. The target site 
was centered over the root apex of the 
maxillary incisors or canines and anesthetic 
solution was deposited at the rate of 1 mL/min. 
After administration of local anesthesia and 
application of rubber dam, access cavity was 
prepared. The root canals were instrumented 
using step-back technique and hand files. 
Sterile saline solution was used as the irrigant. 
Then all root canals were filled with gutta-
percha by lateral condensation technique by 
one operator.  
Root canal therapy was carried out identically 
in one visit for all 30 patients. Patients were 
instructed to rate any occurring pain during the 
endodontic procedure using VAS. Treatment 
was deemed successful if no pain or mild 
discomfort (VAS score of 0 or 1) was felt during 
access cavity preparation and instrumentation. 
A questionnaire was given to the patient at the 
end of the appointment. Patients were taught 
how to assess and record the incidence and 
severity of pain at 2, 4, 6, 8, 10, 12, 24, 36 and 
48 hours after the appointment.  
Anesthetic success and the degree of post-
operative pain among the two groups were 
analyzed using One-way analysis of variance 
(ANOVA). Comparisons were also made to 
evaluate the relation of pain with the other 
contributing factors such as sex and age with 
independent t test. Comparisons were 
considered significant if P was less than 0.05.  
Results  
All 30 recruited volunteers completed the trial. 
The results of this study were divided into five 
reports as outlined below.  
1- Mean of post-operative pain in bupivacaine 
and lidocaine groups differed significantly 
(P<0.05). The mean of post-operative pain in 
the bupivacaine group was less than the 
lidocaine group (Figure 1A). 
2- Relation of age and pain without considering 
the kind of anesthetic drug: patients were 
divided into two groups; less than 40 years (16 
patients) and more than 40 years (14 patients). 
There was no significant difference between 
these two groups (Figure 1B).  
3- Relation of pre- and post-operative pain: 
without considering the kind of anesthetic drug, 
there was a significant difference between pre- 
and post-operative pain (P<0.05).  
4- Relation of gender and the amount of pain 
without considering the kind of anesthetic drug: 
post-operative pain in women was significantly 
greater (P<0.01) (Figure 1C).  
5- Corresponding impression between gender 
and time: males and females showed 
differences in the average of pain at different 
times after treatment. Maximum pain felt in 
men was four hours post operation and 
decreased gradually. However, women 
experienced maximum pain 12 hours after 
treatment, and this decreased sharply after 12 
hours (Figure 1). 
 
Discussion 
Reduction of post-operative pain is of para-
mount importance for patient and dentist. The 
aim of this study was to evaluate the use of long 
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It was hypothesized that long acting anesthetic 
like bupivacaine would cause effective 
anesthesia at time of treatment and also would 
be effective in controlling post-operative pain. 
In the present study the correlation between 
pre- and post-operative pain is significant and 
conforms to O'Keefe et al. (24). They showed 
that the probability of post-operative pain in 
patient with moderate to severe preoperative 
pain was five times greater than those with a 
slight pain before treatment. Yesilsoy et al. 
have declared the same conclusion (25).  
The effectiveness of bupivacaine in decreasing 
pain post-operation in endodontics was 
confirmed by Moore and Dunsky’s study (2). 
Their research showed that patients treated with 
lidocaine had significantly more pain after 
treatment compared with bupivacaine group. 
Gozal et al.'s thyroid surgery study as well as 
Chapman’s investigation showed decrease of 
postoperative pain with bupivacaine in surgery, 
concurring with our study (19,26). 
Nespeca et al. compared bupivacaine with 
lidocaine. They found that post-operative pain 
and use of analgesics were less in the 
bupivacaine group than the lidocaine group. 
They also found that there was no significant 
difference between 0.25% and 0.5% of 
bupivacaine (27). Studies on third molar 
surgery showed that bupivacaine significantly 
decreased post-operative pain and the need for 
the analgesic drugs compared to short-acting 
anesthetics (20-22). Crout's et al.'s first study, 
lidocaine was compared with etidocaine and 
they concluded that etidocaine increased time 
of no pain; lidocaine group used more 
analgesics. In the second study, etidocaine was 
compared to bupivacaine and there was no 
significant difference between these two groups 
in both quality and quantity of anesthesia and 
post operative pain (14).  
Our study shows significant difference between 
male and females in experiencing post-
operation pain; women suffered far more pain 
than men. This concurred with Fox et al.'s 
study (28); however O'Keefe (24), Yesilsoy 
(25), and Clem's (29) studies did not show any 
significant difference between the two genders 
in post-operative pain.  
This study concurred with Yesilosoy et al.'s 
similar investigation which did not show any 
significant difference between the two age 
groups (25). However, Seltzer (30) and 
O'Keefe (24) showed differences in >20 years 
and <20 year age groups; more pain was 
observed in the over 20 years group. It appears 
that the difference in conclusions between these 
two studies and the present study was because 
of the variation in the age groups. 
The reason that bupivacaine is effective in 
reducing pain is likely to be due to its longer 
duration of action; this is because it has 
effective protein binding (23,31).  
We must consider that prolonged lip numbness 
may be disadvantageous and some patients may 
prefer to manage their pain with analgesics 
rather than endure lengthy periods of soft tissue 
anesthesia. However difficulty in eating, 
speaking, and possibility of soft tissue trauma, 
occurs more often in block injections than 
infiltration injections. Also, as the rate of post-
operative pain post-endodontic treatment is as 
follows: 57%, no pain; 21%, mild pain; 15%, 
moderate pain and 7%, severe pain (32), it may 
be wise to utilize long-acting analgesic drugs 
only in patients expecting to have post-
operative moderate or severe pain. 
 
Conclusion  
Within the limitations of this study (low sample 
size) we can safely conclude that bupivacaine 
infiltration injections were more successful 
than lidocaine infiltration for post-endodontic 
pain control in maxillary anterior teeth. 
Moreover, the severity of pain after treatment 
was directly related to the pain before treatment.  
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